ENHERTU® Approved in the EU for Patients with HER2 Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens
Approval broadens indication for Daiichi Sankyo and AstraZeneca’s ENHERTU across Europe to earlier use in…
Approval broadens indication for Daiichi Sankyo and AstraZeneca’s ENHERTU across Europe to earlier use in…
Cloud Software Industry Veteran Michael Haske Succeeds CEO and Co-Founder Olivier Pailhes to Lead Next…
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical…
SINGAPORE - Media OutReach - 19 July 2022 - Okta, the leading independent identity provider,…
HANOI, VIETNAM - Media OutReach - 19 July 2022 - VinFuture Foundation officially launched a…
OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
HashiCorp and Niveus will address major business challenges on the cloud such as minimising cloud…
Amazon files lawsuit against fake review brokers across more than 10,000 groups on Facebook SEATTLE--(BUSINESS…
Global Claims Review 2022: Allianz Global Corporate & Specialty analyzed more than 530,000 insurance claims…
Research performed by Economist Impact, commissioned by the Society of Publishers in Asia and supported…